http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210054006-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c12a2a7eaad13b30d27ce6da591256 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00 |
| filingDate | 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc9c71f08d3ddf49f95c20e126f7f8f |
| publicationDate | 2021-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210054006-A |
| titleOfInvention | Fruit extracts |
| abstract | The present invention is a method for preparing a fruit extract of the eggplant family, and the fruit is treated to optimize the platelet aggregation inhibitory activity of the extract. The method comprises the steps of preparing a homogeneous start mix of fruit; Separating the soluble fraction from the fruit solids; Filtering the aqueous fraction; And concentrating the active substances in the filtrate. The present invention relates to fruit extracts prepared by this method and glycosylated phenolic acid or phenolic acid ester or derivatives thereof; It provides a fruit extract comprising glycosylated flavonoids and nucleosides. The extract of the present invention is useful as a medicament for the treatment or prevention of diseases characterized by inadequate platelet aggregation. In particular, the medicament is the treatment or prevention of a disease characterized by inappropriate platelet aggregation to reduce platelet aggregation to maintain heart health; To benefit circulation; It may be useful to normalize or benefit blood flow. |
| priorityDate | 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 186.